BOTHELL, Wash., Nov. 7 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. , a leader in developing therapeutics that utilize proprietary molecular biology-based drug delivery technologies, will be presenting at the CIBC World Markets Healthcare Conference on Wednesday, November 9, 2005 at 3:00 p.m. Eastern Time at the Waldorf-Astoria in New York City. Gordon Brandt, M.D., Executive Vice President, Clinical Research and Medical Affairs of Nastech, will provide a corporate overview, including a review of the Company’s product development programs.
To access the live audio webcast for this conference, please log on to Nastech’s website at http://www.nastech.com approximately 15 minutes prior to the presentation in order to register and download any necessary software. A replay of the audio presentation will be available following the event.
About Nastech
We are a pharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. We and our collaboration partners are developing products for multiple therapeutic areas including inflammatory conditions, obesity and osteoporosis. Additional information about Nastech is available at http://www.nastech.com.
CONTACTS: Nastech Ed Bell Senior Investor Relations Manager (425) 908-3639 ir@nastech.com Noonan Russo Matthew Haines (Investors/Media) (212) 845-4235
Nastech Pharmaceutical Company Inc.
CONTACT: Ed Bell, Senior Investor Relations Manager of Nastech,+1-425-908-3639, ir@nastech.com; or Matthew Haines, Investors/Media ofNoonan Russo, +1-212-845-4235
Web site: http://www.nastech.com/
